Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Sci Rep ; 9(1): 13449, 2019 09 17.
Artículo en Inglés | MEDLINE | ID: mdl-31530834

RESUMEN

The Burkholderia cepacia complex (Bcc) is a family of closely related bacterial pathogens that are the causative agent of deadly human infections. Virulence in Bcc species has been shown to be controlled by the CepI/CepR quorum sensing (QS) system, which is mediated by an N-acyl L-homoserine lactone (AHL) signal (C8-AHL) and its cognate LuxR-type receptor (CepR). Chemical strategies to block QS in Bcc members would represent an approach to intercept this bacterial communication process and further delineate its role in infection. In the current study, we sought to identify non-native AHLs capable of agonizing or antagonizing CepR, and thereby QS, in a Bcc member. We screened a library of AHL analogs in cell-based reporters for CepR, and identified numerous highly potent CepR agonists and antagonists. These compounds remain active in a Bcc member, B. multivorans, with one agonist 250-fold more potent than the native ligand C8-AHL, and can affect QS-controlled motility. Further, the CepR antagonists prolong C. elegans survival in an infection model. These AHL analogs are the first reported non-native molecules that both directly modulate CepR and impact QS-controlled phenotypes in a Bcc member, and represent valuable chemical tools to assess the role of QS in Bcc infections.


Asunto(s)
Proteínas Bacterianas/antagonistas & inhibidores , Complejo Burkholderia cepacia/efectos de los fármacos , Complejo Burkholderia cepacia/patogenicidad , Percepción de Quorum/efectos de los fármacos , Acil-Butirolactonas/metabolismo , Animales , Proteínas Bacterianas/agonistas , Proteínas Bacterianas/genética , Proteínas Bacterianas/metabolismo , Infecciones por Burkholderia/microbiología , Caenorhabditis elegans/efectos de los fármacos , Evaluación Preclínica de Medicamentos , Escherichia coli/genética , Genes Reporteros , Ligandos , Percepción de Quorum/fisiología , beta-Galactosidasa/genética
2.
Mol Nutr Food Res ; 62(9): e1700992, 2018 05.
Artículo en Inglés | MEDLINE | ID: mdl-29573169

RESUMEN

SCOPE: This study was undertaken to expand our insights into the mechanisms involved in the tolerance to resveratrol (RSV) that operate at system-level in gut microorganisms and advance knowledge on new RSV-responsive gene circuits. METHODS AND RESULTS: Whole genome transcriptional profiling was used to characterize the molecular response of Lactobacillus plantarum WCFS1 to RSV. DNA repair mechanisms were induced by RSV and responses were triggered to decrease the load of copper, a metal required for RSV-mediated DNA cleavage, and H2 S, a genotoxic gas. To counter the effects of RSV, L. plantarum strongly up- or downregulated efflux systems and ABC transporters pointing to transport control of RSV across the membrane as a key mechanism for RSV tolerance. L. plantarum also downregulated tRNAs, induced chaperones, and reprogrammed its transcriptome to tightly control ammonia levels. RSV induced a probiotic effector gene and a likely deoxycholate transporter, two functions that improve the host health status. CONCLUSION: Our data identify novel protective mechanisms involved in RSV tolerance operating at system level in a gut microbe. These insights could influence the way RSV is used for a better management of gut microbial ecosystems to obtain associated health benefits.


Asunto(s)
Antioxidantes/metabolismo , Proteínas Bacterianas/metabolismo , Reparación del ADN , Regulación Bacteriana de la Expresión Génica , Lactobacillus plantarum/metabolismo , Modelos Biológicos , Resveratrol/metabolismo , Animales , Proteínas Bacterianas/agonistas , Proteínas Bacterianas/antagonistas & inhibidores , Proteínas Bacterianas/genética , Transporte Biológico , Cobre/química , Cobre/metabolismo , Ácidos Cumáricos , Suplementos Dietéticos , Perfilación de la Expresión Génica , Ontología de Genes , Humanos , Sulfuro de Hidrógeno/antagonistas & inhibidores , Sulfuro de Hidrógeno/metabolismo , Lactobacillus plantarum/crecimiento & desarrollo , Lactobacillus plantarum/aislamiento & purificación , Probióticos , Propionatos/metabolismo , ARN Bacteriano/antagonistas & inhibidores , ARN Bacteriano/metabolismo , ARN de Transferencia/antagonistas & inhibidores , ARN de Transferencia/metabolismo , Saliva/microbiología
3.
Future Med Chem ; 9(17): 1983-1994, 2017 11.
Artículo en Inglés | MEDLINE | ID: mdl-29076756

RESUMEN

AIM: Resistance to conventional antibiotics has spurred interest in exploring new antimicrobial strategies. Suppressing quorum sensing within biofilm is a promising antimicrobial strategy. LasR in quorum sensing system of the Gram-negative bacteria, Pseudomonas aeruginosa, directly enhances virulence and antibiotic resistance, with QscR as its indirect suppressor, so targeting both of them can synergistically take the effect. METHODOLOGY/RESULTS: An in silico protocol combining pharmacophores with molecular docking was applied. Pharmacophores of QscR agonists and LasR antagonists were prepared for preliminary screening, followed by counter-screen using a pharmacophore model of LasR agonists and molecular docking of LasR. Four compounds with novel scaffolds were confirmed as potential biofilm inhibitors with preliminary experimental data. CONCLUSION: Novel biofilm inhibitors can be found with the method.


Asunto(s)
Antibacterianos/farmacología , Proteínas Bacterianas/agonistas , Proteínas Bacterianas/antagonistas & inhibidores , Biopelículas/efectos de los fármacos , Pseudomonas aeruginosa/efectos de los fármacos , Percepción de Quorum/efectos de los fármacos , Proteínas Represoras/agonistas , Transactivadores/antagonistas & inhibidores , Antibacterianos/química , Evaluación Preclínica de Medicamentos , Pruebas de Sensibilidad Microbiana , Modelos Moleculares , Relación Estructura-Actividad
4.
Molecules ; 22(1)2017 Jan 14.
Artículo en Inglés | MEDLINE | ID: mdl-28098806

RESUMEN

Medicinal plants are frequently used for the treatment of various infectious diseases. The objective of this study was to evaluate the antibacterial activity and mode of action of Acacia nilotica and the antibiogram patterns of foodborne and clinical strains of Escherichia coli and Salmonella. The mechanism of action of acacia extracts against E. coli and Salmonella was elucidated by observing morphological damages including cell integrity and cell membrane permeability, as well as changes in cell structures and growth patterns in kill-time experiments. The clinical isolates of E. coli and Salmonella were found resistant to more of the tested antibiotics, compared to food isolates. Minimum inhibitory concentration and minimum bactericidal concentration of acacia leaf extracts were in the ranges of 1.56-3.12 mg/mL and 3.12-6.25 mg/mL, respectively, whereas pods and bark extracts showed somewhat higher values of 3.12-6.25 mg/mL and 6.25-12.5 mg/mL, respectively, against all tested pathogens. The release of electrolytes and essential cellular constituents (proteins and nucleic acids) indicated that acacia extracts damaged the cellular membrane of the pathogens. These changes corresponded to simultaneous reduction in the growth of viable bacteria. This study indicates that A. nilotica can be a potential source of new antimicrobials, effective against antibiotic-resistant strains of pathogens.


Asunto(s)
Acacia/química , Antibacterianos/farmacología , Proteínas Bacterianas/agonistas , ADN Bacteriano/agonistas , Escherichia coli/efectos de los fármacos , Salmonella/efectos de los fármacos , Antibacterianos/aislamiento & purificación , Proteínas Bacterianas/metabolismo , Membrana Celular/efectos de los fármacos , Membrana Celular/metabolismo , Permeabilidad de la Membrana Celular/efectos de los fármacos , ADN Bacteriano/metabolismo , Farmacorresistencia Bacteriana Múltiple/efectos de los fármacos , Escherichia coli/crecimiento & desarrollo , Escherichia coli/metabolismo , Escherichia coli/ultraestructura , Pruebas de Sensibilidad Microbiana , Extractos Vegetales/química , Hojas de la Planta/química , Salmonella/crecimiento & desarrollo , Salmonella/metabolismo , Salmonella/ultraestructura
5.
Genet Mol Res ; 14(2): 6723-32, 2015 Jun 18.
Artículo en Inglés | MEDLINE | ID: mdl-26125881

RESUMEN

We explored the mechanism of the development from sensitivity to resistance to carbapenem in Pseudomonas aeruginosa. Two P. aeruginosa strains were collected during treatment with carbapenem. Strain homology was investigated using pulsed-field gel electrophoresis. Porin oprD2 expression was analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). The minimum inhibitory concentrations (MICs) of imipenem and meropenem with or without MC207110 were determined using the agar dilution method. The expression level of efflux pump mRNA was tested using real-time polymerase chain reaction. Metallo-lactamases (MBLs) were screened using the EDTA-disk synergy test. Genes encoding MBLs were amplified and then analyzed by DNA sequencing. The two treated strains belonged to the same pulsed-field gel electrophoresis type. The SDS-PAGE profile of the P. aeruginosa strains revealed that the 46-kDa membrane protein OprD2 of IMP(R)MEM(R) type strains was lost, whereas OprD2 of 1 IMP(S)MEM(S) strain was normal. With or without MC207110 treatment, the MIC of carbapenem-resistant P. aeruginosa decreased by 4-fold, while the MIC of carbapenem-sensitive P. aeruginosa did not. Compared with the carbapenem-sensitive strain, MexX mRNA expression in the carbapenem-resistant strain increased by 102.5-fold, while the mRNA expression of other efflux pumps did not markedly increase. Neither carbapenem-resistant nor carbapenem-sensitive P. aeruginosa produced MBL. The mechanism of development from sensitivity to resistance of P. aeruginosa to carbapenem during carbapenem treatment is due to porin oprD2 loss and an increased expression level of MexXY-OprM.


Asunto(s)
Antibacterianos/farmacología , Proteínas de la Membrana Bacteriana Externa/genética , Proteínas Bacterianas/genética , Regulación Bacteriana de la Expresión Génica , Proteínas de Transporte de Membrana/genética , Porinas/genética , Pseudomonas aeruginosa/genética , Resistencia betalactámica/genética , Proteínas de la Membrana Bacteriana Externa/agonistas , Proteínas de la Membrana Bacteriana Externa/metabolismo , Proteínas Bacterianas/agonistas , Proteínas Bacterianas/metabolismo , Dipéptidos/farmacología , Combinación de Medicamentos , Electroforesis en Gel de Campo Pulsado , Electroforesis en Gel de Poliacrilamida , Imipenem/farmacología , Proteínas de Transporte de Membrana/agonistas , Proteínas de Transporte de Membrana/metabolismo , Meropenem , Pruebas de Sensibilidad Microbiana , Porinas/deficiencia , Pseudomonas aeruginosa/efectos de los fármacos , Pseudomonas aeruginosa/metabolismo , Tienamicinas/farmacología , Resistencia betalactámica/efectos de los fármacos , beta-Lactamasas/genética , beta-Lactamasas/metabolismo
6.
Bioorg Med Chem ; 19(16): 4812-9, 2011 Aug 15.
Artículo en Inglés | MEDLINE | ID: mdl-21798749

RESUMEN

Quorum sensing (QS) is a cell-cell signaling mechanism that allows bacteria to monitor their population size and alter their behavior at high cell densities. Gram-negative bacteria use N-acylated L-homoserine lactones (AHLs) as their primary signals for QS. These signals are susceptible to lactone hydrolysis in biologically relevant media, and the ring-opened products are inactive QS signals. We have previously identified a range of non-native AHLs capable of strongly agonizing and antagonizing QS in Gram-negative bacteria. However, these abiotic AHLs are also prone to hydrolysis and inactivation and thereby have a relatively short time window for use (∼12-48 h). Non-native QS modulators with reduced or no hydrolytic instability could have enhanced potencies and would be valuable as tools to study the mechanisms of QS in a range of environments (for example, on eukaryotic hosts). This study reports the design and synthesis of two libraries of new, non-hydrolyzable AHL mimics. The libraries were screened for QS modulatory activity using LasR, LuxR, and TraR bacterial reporter strains, and several new, abiotic agonists and antagonists of these receptors were identified.


Asunto(s)
Acil-Butirolactonas/metabolismo , Diseño de Fármacos , Bacterias Gramnegativas/efectos de los fármacos , Percepción de Quorum/efectos de los fármacos , Proteínas Represoras/efectos de los fármacos , Transactivadores/efectos de los fármacos , Acil-Butirolactonas/síntesis química , Acil-Butirolactonas/química , Acil-Butirolactonas/farmacología , Proteínas Bacterianas/agonistas , Proteínas Bacterianas/antagonistas & inhibidores , Proteínas Bacterianas/efectos de los fármacos , Proteínas Bacterianas/genética , Evaluación Preclínica de Medicamentos , Estabilidad de Medicamentos , Genes Reporteros/efectos de los fármacos , Bacterias Gramnegativas/fisiología , Lactonas/metabolismo , Terapia Molecular Dirigida , Proteínas Represoras/agonistas , Proteínas Represoras/genética , Proteínas Represoras/fisiología , Transactivadores/agonistas , Transactivadores/antagonistas & inhibidores , Transactivadores/genética , Transactivadores/fisiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA